Connect with us

Financial News

Novo Nordisk’s ‘long game’ on weight loss drugs sparks hope in science, but the Street is impatient

Novo Nordisk’s ‘long game’ on weight loss drugs sparks hope in science, but the Street is impatient

The medicine developed by the100-year old Danish drugmaker may impact patients’ brains in surprising waysRead More

More in Financial News